Mechanism of the antiviral action of 1-β-D-arabinofuranosylcytosine on Borna disease virus

Journal of Virology

Volumn 79, Issue 7, 2005, Pages 4514-4518

  Volmer, Romain ^a,b   Bajramovic, Jeffrey J ^b   Schneider, Urs ^c   Ufano, Sandra ^d   Pochet, Sylvie ^b   Gonzalez Dunia, Daniel ^a,b,e  

^a INSERM   (France)

^b INSTITUT PASTEUR   (France)

^c UNIVERSITY OF FREIBURG   (Germany)

^d CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^e CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

5 CHLORO CYTARABINE; 5' DEOXY CYTARABINE; CYTARABINE; CYTARABINE TRIPHOSPHATE; CYTIDINE; CYTOSINE; DEOXYCYTIDINE; DNA POLYMERASE; HYPOXANTHINE ARABINOSIDE; NUCLEOSIDE DERIVATIVE; NUCLEOTIDE; UNCLASSIFIED DRUG; URACIL ARABINOSIDE;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; BORNA DISEASE; BORNA DISEASE VIRUS; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; DRUG STRUCTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RNA VIRUS; STRUCTURE ACTIVITY RELATION; VIRUS INHIBITION; VIRUS REPLICATION;

ANTIVIRAL AGENTS; BORNA DISEASE VIRUS; CYTARABINE; ENZYME INHIBITORS; VIRUS REPLICATION;

EID: 15244341700     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.7.4514-4518.2005     Document Type: Article

References (32)

1. Bajramovic, J. J., S. Syan, M. Brahic, J. C. De La Torre, and D. Gonzalez-Dunia. 2002. 1-β-D-Arabinofuranosylcytosine inhibits Borna disease virus replication and spread. J. Virol. 76:6268-6276.
2. Bajramovic, J. J., R. Volmer, S. Syan, S. Pochet, and D. Gonzalez-Dunia. 2004. 2′-Fluoro-2′-deoxycytidine inhibits Borna disease virus replication and spread. Antimicrob. Agents Chemother. 48:1422-1425.
3. Bhalla, K., P. Swerdlow, and S. Grant. 1991. Effects of thymidine and hydroxyurea on the metabolism and cytotoxicity of 1-β-D arabinofuranosylcytosine in highly resistant human leukemia cells. Blood 78:2937-2944.
4. Bode, L., D. E. Dietrich, R. Stoyloff, H. M. Emrich, and H. Ludwig. 1997. Amantadine and human Borna disease virus in vitro and in vivo in an infected patient with bipolar depression. Lancet 349:178-179.
5. Bode, L., and H. Ludwig. 2003. Borna disease virus infection, a human mental-health risk. Clin. Microbiol. Rev. 16:534-545.
6. Bressanelli, S., L. Tomei, A. Roussel, I. Incitti, R. L. Vitale, M. Mathieu, R. De Francesco, and F. A. Rey. 1999. Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus. Proc. Natl. Acad. Sci. USA 96:13034-13039.
7. Briese, T., W. I. Lipkin, and J. C. de la Torre. 1995. Molecular biology of Borna disease virus. Curr. Top. Microbiol. Immunol. 190:1-16.
8. Cubitt, B., and J. C. de la Torre. 1997. Amantadine does not have antiviral activity against Borna disease virus. Arch. Virol. 142:2035-2042.
9. Cubitt, B., and J. C. de la Torre. 1994. Borna disease virus (BDV), a nonsegmented RNA virus, replicates in the nuclei of infected cells where infectious BDV ribonucleoproteins are present. J. Virol. 68:1371-1381.
10. Cubitt, B., C. Oldstone, and J. C. de la Torre. 1994. Sequence and genome organization of Borna disease virus. J. Virol. 68:1382-1396.
11. Delarue, M., O. Poch, N. Tordo, D. Moras, and P. Argos. 1990. An attempt to unify the structure of polymerases. Protein Eng. 3:461-467.
12. de la Torre, J. C., K. Carbone, P. Staeheli, L. Stitz, J. A. Rieht, K. Ikuta, B. Dietzschold, H. Ludwig, L. Bode, and W. I. Lipkin. 2000. Family Bornaviridae, p. 531-538. In M. H. V. van Regenmortel, C. M. Fauquet, D. H. L. Bishop, E. B. Carstens, M. K. Estes, S. M. Lemon, J. Maniloff, M. A. Mayo, D. J. McGeoch, C. R. Pringle, and R. B. Wicker (ed.), Virus taxonomy: classification and nomenclature of viruses. Seventh report of the International Committee on Taxonomy of Viruses. [Online.] Academic Press, San Diego, Calif. doi:10.1006/bkvt.2000.0052.
13. Dürrwald, R., and H. Ludwig. 1997. Borna disease virus (BDV), a (zoonotic?) worldwide pathogen. A review of the history of the disease and the virus infection with comprehensive bibliography. Zentbl. Veterinarmed. B 44:147-184.
14. Furth, J. J., and S. S. Cohen. 1968. Inhibition of mammalian DNA polymerase by the 5′-triphosphate of 1-β-D-arabinofuranosylcytosine and the 5′-triphosphate of 9-β-D-arabinofuranoxyladenine. Cancer Res. 28:2061-2067.
15. Gosztonyi, G., B. Dietzschold, M. Kao, C. E. Rupprecht, H. Ludwig, and H. Koprowski. 1993. Rabies and Borna disease. A comparative pathogenetic study of two neurovirulent agents. Lab. Investig. 68:285-295.
16. Gosztonyi, G., and H. Ludwig. 1995. Borna disease-neuropathology and pathogenesis. Curr. Top. Microbiol. Immunol. 190:39-73.
17. Hallensleben, W., M. Zocher, and P. Staeheli. 1997. Borna disease virus is not sensitive to amantadine. Arch. Virol. 142:2043-2048.
18. Hrebabecky, H., J. Brokes, and J. Beranek. 1980. Reaction of nucleosides with thionyl chloride; preparation of the deoxy derivatives of cytidine and adenosine. Collect. Czech. Chem. Commun. 45:599-605.
19. Ikuta, K., M. S. Ibrahim, T. Kobayashi, and K. Tomonaga. 2002. Borna disease virus and infection in humans. Front. Biosci. 7:470-495.
20. Jordan, I., T. Briese, D. R. Averett, and W. I. Lipkin. 1999. Inhibition of Borna disease virus replication by ribavirin. J. Virol. 73:7903-7906.
21. Larder, B. A., D. J. Purifoy, K. L. Powell, and G. Darby. 1987. Site-specific mutagenesis of AIDS virus reverse transcriptase. Nature 327:716-717.
22. Ludwig, H., and L. Bode. 2000. Borna disease virus: new aspects on infection, disease, diagnosis and epidemiology. Rev. Sci. Tech. 19:259-288.
23. Mizutani, T., H. Inagaki, K. Araki, H. Kariwa, J. Arikawa, and I. Takashima. 1998. Inhibition of Borna disease virus replication by ribavirin in persistently infected cells. Arch. Virol. 143:2039-2044.
24. Mizutani, T., H. Inagaki, D. Hayasaka, H. Kariwa, and I. Takashima. 1999. Enhancement of Borna disease virus transcription in persistently infected cells by serum starvation. J. Vet. Med. Sci. 61:831-834.
25. Perez, M., A. Sanchez, B. Cubitt, D. Rosario, and J. C. de la Torre. 2003. A reverse genetics system for Borna disease virus. J. Gen. Virol. 84:3099-3104.
26. Planz, O., K. Rechter, and M. Schwemmle. 2002. Human Borna disease virus infection, p. 179-226. In K. Carbone (ed.), Borna disease virus and its role in neurobehavioral disease. ASM Press, Washington, D.C.
27. Pletnikov, M., D. Gonzalez-Dunia, and L. Stitz. 2002. Experimental infection: pathogenesis of neurobehavioral disease, p. 125-178. In K. Carbone (ed.), Borna disease virus and its role in neurobehavioral disease. ASM Press, Washington, D.C.
28. Poch, O., I. Sauvaget, M. Delarue, and N. Tordo. 1989. Identification of four conserved motifs among the RNA-dependent polymerase encoding elements. EMBO J. 8:3867-3874.
29. Schneider, U., M. Naegele, P. Staeheli, and M. Schwemmle. 2003. Active Borna disease virus polymerase complex requires a distinct nucleoprotein-to- phosphoprotein ratio but no viral X protein. J. Virol. 77:11781-11789.
30. Solbrig, M. V., R. Schlaberg, T. Briese, N. Horscroft, and W. I. Lipkin. 2002. Neuroprotection and reduced proliferation of microglia in ribavirin-treated bornavirus-infected rats. Antimicrob. Agents Chemother. 46:2287-2291.
31. Staeheli, P., C. Sauder, J. Hausmann, F. Ehrensperger, and M. Schwemmle. 2000. Epidemiology of Borna disease virus. J. Gen. Virol. 81:2123-2135.
32. Stitz, L., O. Planz, and T. Bilzer. 1998. Lack of antiviral effect of amantadine in Borna disease virus infection. Med. Microbiol. Immunol. 186: 195-200.